In this episode, Dr. Paul Wheatley-Price speaks with Dr. Christian Finley, Co-Chair of the Pan-Canadian Lung Cancer Action Plan Steering Committee and Professor at McMaster University. They explore the newly released 2026–2035 Pan-Canadian Lung Cancer Action Plan - an ambitious national roadmap to reduce lung cancer deaths by 30% over the next decade. Lung Cancer Canada has been actively involved on the Steering Committee helping shape the Plan, and continues to be engaged as this work moves into implementation. Learn more at https://cancer.ca/en/about-us/lung-cancer-action-plan

Dans cet épisode, Dre Nathalie Daaboul s’entretient avec Mme Annick Dufour, pharmacienne en oncologie à l'Hôpital Charles-Le Moyne à Montreal, à propos du rôle essentiel des pharmaciens dans la prise en charge du cancer du poumon. Ensemble, elles expliquent en quoi consiste la pharmacie en oncologie, comment les pharmaciens collaborent avec l’équipe médicale, et leur rôle dans la préparation, la validation et l’ajustement des traitements. Elles abordent également la gestion des effets secondaires, l’importance du suivi des analyses sanguines, ainsi que les contributions des pharmaciens pour assurer des soins sécuritaires et adaptés aux patients.

In this episode, Dr. Paul Wheatley-Price chats with Dr. Ines Menjak, Medical Oncologist at Sunnybrook Health Sciences Centre in Toronto, about the 2026 landscape of immunotherapy treatment for lung cancer. What exactly is immunotherapy, how does it work, when is it used, common side effects to expect, what are the latest drugs, and what's coming down the pipeline.

In this episode, Dr. Paul Wheatley-Price chats with Dr. Lisa Hicks, a hematologist-oncologist at St. Michael’s Hospital, who specializes in caring for medically and socially complex people with blood cancer. They talk about the unique neighbourhood that she serves in downtown Toronto, what are the social determinants of health, how various aspects of poverty and societal inequity might impact those with a lung cancer (or other cancer) diagnosis.

Dans cet épisode, la Dre Nathalie Daaboul s’entretient avec la Dre Myriam Bouchard, radio-oncologue au Centre Hospitalier Universitaire de Sherbrooke, afin de démystifier la radiothérapie dans le traitement du cancer du poumon. Ensemble, elles expliquent quand et pourquoi la radiothérapie est utilisée, les avancées qui rendent les traitements plus précis et mieux tolérés, comment les effets secondaires sont pris en charge, et pourquoi une approche humaine et multidisciplinaire est essentielle pour accompagner les patients tout au long de leur parcours de soins.

In our second episode of the "Perspectives" series, Dr. Paul Wheatley-Price chats with two guests, both with a depth of experience in ROS1+ lung cancer, a rare subtype of non-small cell lung cancer (NSCLC) which represents only about 1-2% of all lung cancer cases in Canada. Rev. Richard Reimer from Edmonton shares his story being diagnosed in 2009 with stage 4 lung cancer that was later identified as ROS1, and how he's been navigating life ever since. Dr. Geoffrey Liu is a Medical Oncologist at the Princess Margaret Cancer Center in Toronto and provides his clinical expertise on what is ROS1, how common is it, how does it get tested, and what the current treatment options are for those diagnosed with this rare subtype of lung cancer. This episode is dedicated to Richard's beloved wife, Dana Rayment ❤️

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec la Dre Catherine Labbé, pneumologue spécialisée en oncologie pulmonaire à l'Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ), au sujet de tout ce qu'il faut savoir sur le dépistage du cancer du poumon : qui est admissible, quels sont les critères et pourquoi est-il important de se faire dépister si vous présentez un risque élevé ?

In our new series called Perspectives on Lung Cancer, Dr. Paul Wheatley-Price sits down with two guests, both with a depth of experience in ALK+ lung cancer, which represents about 4-8% of all lung cancer cases in Canada. Dr. Cheryl Ho, medical oncologist at BC Cancer, provides her perspective as a physician treating these types of cancers in her daily practice, while Katie Hulan shares her journey as a patient diagnosed with ALK+ lung cancer in 2021, navigating the healthcare system, and her path to launching ALK Positive Canada to advocate for better awareness of this subtype of lung cancer.

Dans cet épisode, la Dre Nathalie Daaboul s'entretient avec le Dr Kevin Jao, coprésident du comité médical consultatif de Cancer pulmonaire Canada et hémato-oncologue à l'Hôpital du Sacré-Cœur-de-Montréal. Ils présentent Cancer pulmonaire Canada, tout le soutien et les ressources disponibles pour les Canadiens touchés par le cancer du poumon, et mettent particulièrement l'accent sur le Mois de la sensibilisation au cancer du poumon.

In this episode, Dr. Paul Wheatley-Price is back for our annual recap of the IASLC 2025 World Conference on Lung Cancer (WCLC), which took place in Barcelona, Spain in early September. He is joined by two special guests, Dr. Barbara Melosky, Professor of Medicine at UBC and Medical Oncologist at BC Cancer, and Dr. Peter Ellis, Professor of Oncology at McMaster University and Medical Oncologist at Juravinski Cancer Center. They chat about all the updates for treatments like osimertinib for EGFR+ lung cancer, immunotherapy for small-cell lung cancer, and promising new treatments like for HER2 and ADCs coming down the pipeline.